Pub. Date : 2018 Nov 2
PMID : 30301525
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Chronic myeloid leukemia (CML) responds well to BCR-ABL tyrosine kinase inhibitors (TKI), such as imatinib and dasatinib. | Dasatinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |